USANA Health Sciences Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
USANA Health Sciences Stock Forecast and Price Target
The average target price set lately by experts for USANA Health Sciences to reach by the end of the year is $56.50, which would imply a potential upside of approximately 30.97 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $65.00 and a low estimate of $48.00. Even if you are not interested in USNA stock, you should be aware of its competitors and their current standings.
30.97% Upside
USANA Health Sciences Fair Value Forecast for 2023 - 2025 - 2030
In the last five years, USANA Health Sciences's Price has gone down from $103.72 to $0.00 – a 100.00% drop. For next year, analysts predict Fair Value of $54.16, which would mean an increase of 100.00%. Over the next seven years, experts predict that USANA Health Sciences's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WMT Stock Forecast | Walmart Inc | Outperform |
15
|
$60.21 | Buy/Sell | $179.15 | 9.62% |
| NESN Stock Forecast | Nestlé | Outperform |
11
|
CHF92.08 | Buy/Sell | CHF115.58 | 19.46% |
| CVS Stock Forecast | CVS Health | Outperform |
12
|
$67.33 | Buy/Sell | $89.54 | 29.66% |
| PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$31.27 | Buy/Sell | $44.75 | 26.64% |
| SMPL Stock Forecast | Simply Good Foods Co-The | Outperform |
15
|
$34.62 | Buy/Sell | $40.58 | 18.43% |
USANA Health Sciences Revenue Forecast for 2023 - 2025 - 2030
In the last zero years, USANA Health Sciences's Revenue has gone down from $1.13B to $1.13B – a 0.00% drop. In the next year, 2 analysts estimate that USANA Health Sciences's Revenue will decrease by 19.39%, reaching $914.61M. According to professional forecasts, in 2030, USANA Health Sciences's Revenue will decrease by 12.80%, reaching $989.40M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HLF Stock Forecast | Herbalife | Outperform |
16
|
$8.88 | Buy/Sell | $17.90 | 12.61% |
| NUS Stock Forecast | Nu Skin Enterprises | Hold |
18
|
$12.24 | Buy/Sell | $21.00 | 14.38% |
| HAIN Stock Forecast | The Hain Celestial Group | Outperform |
14
|
$6.09 | Buy/Sell | $12.33 | 64.20% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MED Stock Forecast | Medifast | Hold |
18
|
$33.50 | Buy/Sell | $69.50 | 11.94% |
| NATR Stock Forecast | Nature's Sunshine Products | Buy |
16
|
$19.42 | Buy/Sell | $21.50 | 23.58% |
| LWAY Stock Forecast | Lifeway Foods | Outperform |
10
|
$21.49 | Buy/Sell | $13.00 | 3.54% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PETS Stock Forecast | PetMed Express | Hold |
16
|
$5.12 | Buy/Sell | $9.75 | 90.43% |
| WW Stock Forecast | WW International | Outperform |
16
|
$1.59 | Buy/Sell | $11.79 | 230.19% |
| LFVN Stock Forecast | LifeVantage |
0
|
$6.24 | Buy/Sell | $7.00 | -100.00% |
USANA Health Sciences EBITDA Forecast for 2023 - 2025 - 2030
In the last zero years, USANA Health Sciences's EBITDA has decreased by 0.00%, going from $190.24M to $190.24M. 1 analysts predict USANA Health Sciences's EBITDA will decrease by 41.60% in the next year, reaching $111.10M. By 2030, professionals predict that USANA Health Sciences's EBITDA will decrease by 26.42%, to $139.98M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NHTC Stock Forecast | Natural Health Trends | - |
0
|
$6.65 | Buy/Sell | $30.00 | -100.00% |
| FARM Stock Forecast | Farmer Bros. | Outperform |
11
|
$3.13 | Buy/Sell | $6.00 | 91.69% |
| TUP Stock Forecast | Tupperware Brands | - |
18
|
$1.04 | Buy/Sell | $4.00 | -100.00% |
USANA Health Sciences EBIT Forecast for 2023 - 2025 - 2030
In the last zero years, USANA Health Sciences's EBIT has decreased from $176.49M to $176.49M – a 0.00% drop. For the following year, the 2 analysts predict that USANA Health Sciences's EBIT will drop by 50.99%, reaching $86.50M. In 2030, the professionals' prediction is that USNA's EBIT will decrease by 30.65%, reaching $122.40M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NAII Stock Forecast | Natural Alternatives Internati... | - |
0
|
$6.25 | Buy/Sell | $0.00 | -100.00% |
| MTEX Stock Forecast | Mannatech | - |
12
|
$8.11 | Buy/Sell | $200.00 | -100.00% |
| RELV Stock Forecast | Reliv' International | - |
0
|
$3.85 | Buy/Sell | $21.00 | -100.00% |
USANA Health Sciences EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last five years, USANA Health Sciences's EPS has gone down from $5.86 to $0.00 – a 100.00% drop. For next year, analysts predict EPS of $3.06, which would mean an increase of 100.00%. Over the next seven years, experts predict that USANA Health Sciences's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| UMHL Stock Forecast | Umatrin Holding | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| YGYI Stock Forecast | Youngevity International | - |
0
|
$0.01 | Buy/Sell | $6.00 | -100.00% |
| MSLP.Q Stock Forecast | MusclePharm | - |
0
|
$0.00 | Buy/Sell | $1.65 | 0.00% |
Site Navigation
.jpg)